CoChat

Importance of Glutamate Dehydrogenase (GDH) in Clostridium difficile Colonization In Vivo

Open access
Girinathan, Brintha Parasumanna, Braun, Sterling, Sirigireddy, Apoorva Reddy, Lopez, Jose Espinola, Govind, Revathi · 2016 · PLOS ONE
Cited by 33

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Clostridium difficile is the principal cause of antibiotic-associated diarrhea. Major metabolic requirements for colonization and expansion of C. difficile after microbiota disturbance have not been fully determined. In this study, we show that glutamate utilization is important for C. difficile to establish itself in the animal gut. When the gluD gene, which codes for glutamate dehydrogenase (GDH), was disrupted, the mutant C. difficile was unable to colonize and cause disease in a hamster model. Further, from the complementation experiment it appears that extracellular GDH may be playing a role in promoting C. difficile colonization and disease progression. Quantification of free amino acids in the hamster gut during C. difficile infection showed that glutamate is among preferred amino acids utilized by C. difficile during its expansion. This study provides evidence of the importance of glutamate metabolism for C. difficile pathogenesis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0160107

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 62

  1. JG Bartlett, 2006, Narrative review: the new epidemic of Clostridium difficile-associated enteric disease, Annals of internal medicine, 145, 758, 10.7326/0003-4819-145-10-200611210-00008 · DOI · Paper page
  2. E Dolgin, 2011, 'Game changer' antibiotic and others in works for superbug, Nature medicine, 17, 10, 10.1038/nm0111-10 · doi:10.1038/nm0111-10
  3. T Monaghan, 2008, Recent advances in Clostridium difficile-associated disease, Gut, 57, 850
  4. JG Bartlett, 1978, Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis, Gastroenterology, 75, 778, 10.1016/0016-5085(78)90457-2 · DOI · Paper page
  5. JL Giel, 2010, Metabolism of bile salts in mice influences spore germination in Clostridium difficile, PloS one, 5, e8740, 10.1371/journal.pone.0008740 · DOI · Paper page
  6. V Braun, 1996, Definition of the single integration site of the pathogenicity locus in Clostridium difficile, Gene, 181, 29, 10.1016/S0378-1119(96)00398-8 · DOI · Paper page
  7. DE Voth, 2005, Clostridium difficile toxins: mechanism of action and role in disease, Clinical microbiology reviews, 18, 247, 10.1128/CMR.18.2.247-263.2005 · DOI · Paper page
  8. A Antunes, 2012, Global transcriptional control by glucose and carbon regulator CcpA in Clostridium difficile, Nucleic acids research, 40, 10701, 10.1093/nar/gks864 · DOI · Paper page
  9. L Bouillaut, 2015, Integration of metabolism and virulence in Clostridium difficile, Research in microbiology, 166, 375, 10.1016/j.resmic.2014.10.002 · DOI · Paper page
  10. SS Dineen, 2010, Integration of metabolism and virulence by Clostridium difficile CodY, Journal of bacteriology, 192, 5350, 10.1128/JB.00341-10 · DOI · Paper page
  11. SS Dineen, 2007, Repression of Clostridium difficile toxin gene expression by CodY, Molecular microbiology, 66, 206, 10.1111/j.1365-2958.2007.05906.x · DOI · Paper page
  12. S Karlsson, 1999, Suppression of toxin production in Clostridium difficile VPI 10463 by amino acids, Microbiology, 145, 1683, 10.1099/13500872-145-7-1683 · DOI
  13. S Karlsson, 2000, Toxins, butyric acid, and other short-chain fatty acids are coordinately expressed and down-regulated by cysteine in Clostridium difficile, Infection and immunity, 68, 5881, 10.1128/IAI.68.10.5881-5888.2000 · DOI · Paper page
  14. T Maegawa, 2002, Linkage between toxin production and purine biosynthesis in Clostridium difficile, Journal of medical microbiology, 51, 34, 10.1099/0022-1317-51-1-34 · doi:10.1099/0022-1317-51-1-34
  15. KL Nawrocki, 2016, CodY-dependent Regulation of Sporulation in Clostridium difficile, Journal of bacteriology
  16. L Bouillaut, 2013, Proline-dependent regulation of Clostridium difficile Stickland metabolism, Journal of bacteriology, 195, 844, 10.1128/JB.01492-12 · DOI · Paper page
  17. T Karasawa, 1995, A defined growth medium for Clostridium difficile, Microbiology, 141, 371, 10.1099/13500872-141-2-371 · DOI · Paper page
  18. HA Barker, 1981, Amino acid degradation by anaerobic bacteria, Annual review of biochemistry, 50, 23, 10.1146/annurev.bi.50.070181.000323 · DOI · Paper page
  19. MJ Merrick, 1995, Nitrogen control in bacteria, Microbiological reviews, 59, 604, 10.1128/MMBR.59.4.604-622.1995 · doi:10.1128/mmbr.59.4.604-622.1995 · Paper page
  20. BM Anderson, 1993, Purification and characterization of Clostridium difficile glutamate dehydrogenase, Archives of biochemistry and biophysics, 300, 483, 10.1006/abbi.1993.1065 · doi:10.1006/abbi.1993.1065
  21. KC Carroll, 2011, Tests for the diagnosis of Clostridium difficile infection: the next generation, Anaerobe, 17, 170, 10.1016/j.anaerobe.2011.01.002 · DOI
  22. N Shetty, 2011, The role of glutamate dehydrogenase for the detection of Clostridium difficile in faecal samples: a meta-analysis, The Journal of hospital infection, 77, 1, 10.1016/j.jhin.2010.07.024 · DOI
  23. BP Girinathan, 2014, Clostridium difficile glutamate dehydrogenase is a secreted enzyme that confers resistance to H2O2, Microbiology, 160, 47, 10.1099/mic.0.071365-0 · DOI
  24. JR O'Connor, 2006, Construction and analysis of chromosomal Clostridium difficile mutants, Molecular microbiology, 61, 1335, 10.1111/j.1365-2958.2006.05315.x · DOI · Paper page
  25. AR Sirigi Reddy, 2013, Identification and characterization of Clostridium sordellii toxin gene regulator, Journal of bacteriology, 195, 4246, 10.1128/JB.00711-13 · DOI
  26. JJ Varga, 2006, Type IV pili-dependent gliding motility in the Gram-positive pathogen Clostridium perfringens and other Clostridia, Molecular microbiology, 62, 680, 10.1111/j.1365-2958.2006.05414.x · DOI · Paper page
  27. R Govind, 2015, Observations on the Role of TcdE Isoforms in Clostridium difficile Toxin Secretion, Journal of bacteriology, 197, 2600, 10.1128/JB.00224-15 · DOI
  28. FE Young, 1961, Physiological and genetic factors affecting transformation of Bacillus subtilis, Journal of bacteriology, 81, 823, 10.1128/JB.81.5.823-829.1961 · DOI
  29. F Teng, 1998, Conjugal transfer of plasmid DNA from Escherichia coli to enterococci: a method to make insertion mutations, Plasmid, 39, 182, 10.1006/plas.1998.1336 · DOI
  30. O Okwumabua, 2001, Cloning and characterization of the gene encoding the glutamate dehydrogenase of Streptococcus suis serotype 2, Clinical and diagnostic laboratory immunology, 8, 251, 10.1128/CDLI.8.2.251-257.2001 · doi:10.1128/cdli.8.2.251-257.2001
  31. TW Chang, 1978, Clindamycin-induced enterocolitis in hamsters as a model of pseudomembranous colitis in patients, Infection and immunity, 20, 526, 10.1128/IAI.20.2.526-529.1978 · DOI
  32. SP Sambol, 2001, Infection of hamsters with epidemiologically important strains of Clostridium difficile, The Journal of infectious diseases, 183, 1760, 10.1086/320736 · DOI · Paper page
  33. HW Koon, 2014, Fidaxomicin inhibits Clostridium difficile toxin A-mediated enteritis in the mouse ileum, Antimicrobial agents and chemotherapy, 58, 4642, 10.1128/AAC.02783-14 · DOI
  34. C Pothoulakis, 1994, CP-96,345, a substance P antagonist, inhibits rat intestinal responses to Clostridium difficile toxin A but not cholera toxin, Proceedings of the National Academy of Sciences of the United States of America, 91, 947, 10.1073/pnas.91.3.947 · DOI · Paper page
  35. KE Fujimura, 2010, Role of the gut microbiota in defining human health, Expert review of anti-infective therapy, 8, 435, 10.1586/eri.10.14 · DOI · Paper page
  36. RA Britton, 2014, Role of the intestinal microbiota in resistance to colonization by Clostridium difficile, Gastroenterology, 146, 1547, 10.1053/j.gastro.2014.01.059 · DOI · Paper page
  37. C Feehily, 2013, Role of glutamate metabolism in bacterial responses towards acid and other stresses, Journal of applied microbiology, 114, 11, 10.1111/j.1365-2672.2012.05434.x · DOI · Paper page
  38. RM Wohlheuter, 1973, The Enzymes of Glutamine Metabolism., The Enzymes of Glutamine Metabolism., 45
  39. GA Somerville, 2009, At the crossroads of bacterial metabolism and virulence factor synthesis in Staphylococci, Microbiology and molecular biology reviews: MMBR, 73, 233, 10.1128/MMBR.00005-09 · DOI · Paper page
  40. C Schoen, 2014, Metabolism and virulence in Neisseria meningitidis, Frontiers in cellular and infection microbiology, 4, 114, 10.3389/fcimb.2014.00114 · DOI
  41. K Shibayama, 2007, Metabolism of glutamine and glutathione via gamma-glutamyltranspeptidase and glutamate transport in Helicobacter pylori: possible significance in the pathophysiology of the organism, Molecular microbiology, 64, 396, 10.1111/j.1365-2958.2007.05661.x · DOI
  42. SA Kuehne, 2014, Importance of toxin A, toxin B, and CDT in virulence of an epidemic Clostridium difficile strain, The Journal of infectious diseases, 209, 83, 10.1093/infdis/jit426 · DOI · Paper page
  43. GP Carter, 2015, Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections, mBio, 6, e00551, 10.1128/mBio.00551-15 · DOI · Paper page
  44. KA Fimlaid, 2015, Identification of a Novel Lipoprotein Regulator of Clostridium difficile Spore Germination, PLoS pathogens, 11, e1005239, 10.1371/journal.ppat.1005239 · DOI
  45. X Wu, 2014, The Clostridium difficile proline racemase is not essential for early logarithmic growth and infection, Canadian journal of microbiology, 60, 251, 10.1139/cjm-2013-0903 · DOI
  46. TD Ho, 2014, Clostridium difficile extracytoplasmic function sigma factor sigmaV regulates lysozyme resistance and is necessary for pathogenesis in the hamster model of infection, Infection and immunity, 82, 2345, 10.1128/IAI.01483-13 · DOI · Paper page
  47. D Lyras, 2009, Toxin B is essential for virulence of Clostridium difficile, Nature, 458, 1176, 10.1038/nature07822 · DOI · Paper page
  48. RW McKee, 2013, The second messenger cyclic Di-GMP regulates Clostridium difficile toxin production by controlling expression of sigD, Journal of bacteriology, 195, 5174, 10.1128/JB.00501-13 · DOI
  49. AM Seekatz, 2014, Recovery of the gut microbiome following fecal microbiota transplantation, mBio, 5, e00893, 10.1128/mBio.00893-14 · DOI · Paper page
  50. M Neumann-Schaal, 2015, Time-resolved amino acid uptake of Clostridium difficile 630Deltaerm and concomitant fermentation product and toxin formation, BMC microbiology, 15, 281, 10.1186/s12866-015-0614-2 · DOI
  51. A Pompella, 2003, The changing faces of glutathione, a cellular protagonist, Biochemical pharmacology, 66, 1499, 10.1016/S0006-2952(03)00504-5 · DOI · Paper page
  52. H Xue, 2011, New role of glutamate as an immunoregulator via glutamate receptors and transporters, Frontiers in bioscience, 3, 1007, 10.2741/s205 · doi:10.2741/s205
  53. S Bruzzone, 2001, A self-restricted CD38-connexin 43 cross-talk affects NAD+ and cyclic ADP-ribose metabolism and regulates intracellular calcium in 3T3 fibroblasts, The Journal of biological chemistry, 276, 48300, 10.1074/jbc.M107308200 · DOI · Paper page
  54. M Romanello, 2001, Extracellular NAD(+) induces calcium signaling and apoptosis in human osteoblastic cells, Biochemical and biophysical research communications, 285, 1226, 10.1006/bbrc.2001.5325 · DOI
  55. C Stringari, 2012, Metabolic trajectory of cellular differentiation in small intestine by Phasor Fluorescence Lifetime Microscopy of NADH, Scientific reports, 2, 568, 10.1038/srep00568 · DOI · Paper page
  56. SJ Hwang, 2011, beta-nicotinamide adenine dinucleotide is an enteric inhibitory neurotransmitter in human and nonhuman primate colons, Gastroenterology, 140, 608, 10.1053/j.gastro.2010.09.039 · DOI
  57. X Han, 2003, NAD+ ameliorates inflammation-induced epithelial barrier dysfunction in cultured enterocytes and mouse ileal mucosa, The Journal of pharmacology and experimental therapeutics, 307, 443, 10.1124/jpet.103.056556 · DOI
  58. A Heinrich, 2006, Interaction of the membrane-bound GlnK-AmtB complex with the master regulator of nitrogen metabolism TnrA in Bacillus subtilis, The Journal of biological chemistry, 281, 34909, 10.1074/jbc.M607582200 · DOI
  59. MA Strickler, 2009, Functional characterization of a Na(+)-coupled dicarboxylate transporter from Bacillus licheniformis, Biochimica et biophysica acta, 1788, 2489, 10.1016/j.bbamem.2009.10.008 · doi:10.1016/j.bbamem.2009.10.008
  60. A Gupta, 2014, Community-acquired Clostridium difficile infection: an increasing public health threat, Infection and drug resistance, 7, 63
  61. C Rangan, 2009, Food additives and sensitivities, Disease-a-month: DM, 55, 292, 10.1016/j.disamonth.2009.01.004 · DOI
  62. DM Lyerly, 1991, Identification of the latex test-reactive protein of Clostridium difficile as glutamate dehydrogenase, Journal of clinical microbiology, 29, 2639, 10.1128/JCM.29.11.2639-2642.1991 · DOI · Paper page

Cited by

Metadata

Authors
Girinathan, B. P., Braun, S., Sirigireddy, A. R., Lopez, J. E., & Govind, R.
Venue
PLOS ONE
Published
2016-07-28
Volume
11
Issue
7
Pages
e0160107
ISSN
1932-6203 (ISSN-L)
OpenAlex
W2501071995
Cited by
33
References
1
FWCI
4.20
Type
journal article
Language
en
Open access
gold
Funders
  • National Institute of Allergy and Infectious Diseases (US) (R15AI122173-01)
  • National Institute of General Medical Sciences (P20GM103418, P30496GM103326)
  • National Center for Research Resources (P20RR016475)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.